NCT03283449

Tau PET Imaging in Atypical Dementias

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: University of Chicago · Academic / Other
• Sex: All
• Age: 20 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to demonstrate the feasibility of mapping tau pathology in subjects with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and to systematically document the extent and location of tau pathology in PPA patients in vivo using the same techniques.

Conditions

• Primary Progressive Aphasia With Suspected Alzheimer's Disease

Interventions

Type	Name	Description
DRUG	18F-AV-1451
DEVICE	PET	PET scanner for brain imaging

Timeline

• Start date: 2016-02-01
• Primary completion: 2025-02-28
• Completion: 2025-02-28
• First posted: 2017-09-14
• Last updated: 2025-04-06

Locations

1 site across 1 country: United States